Literature DB >> 18927440

Critical role of class IA PI3K for c-Rel expression in B lymphocytes.

Satoshi Matsuda1, Yohei Mikami, Masashi Ohtani, Mari Fujiwara, Yasuko Hirata, Akiko Minowa, Yasuo Terauchi, Takashi Kadowaki, Shigeo Koyasu.   

Abstract

The fact that the Xid mutation of Btk impairs the ability of pleckstrin homology domain of Btk to bind phosphatidylinositol-(3,4,5)-trisphosphate, a product of class IA phosphoinositide-3 kinases (PI3Ks), has been considered strong evidence for the hypothesis that Btk functions downstream of PI3Ks. We demonstrate here that the Xid mutation renders the Btk protein unstable. Furthermore, class IA PI3K- and Btk-deficient mice show different phenotypes in B-cell development, collectively indicating that PI3Ks and Btk differentially function in BCR signal transduction. Nevertheless, both PI3K and Btk are required for the activation of NF-kappaB, a critical transcription factor family for B-cell development and function. We demonstrate that PI3Ks maintain the expression of NF-kappaB proteins, whereas Btk is known to be essential for IkappaB degradation and the translocation of NF-kappaB to the nucleus. The loss of PI3K activity results in marked reduction of c-Rel and to a lesser extent RelA expression. The lentivirus-mediated introduction of c-Rel corrects both developmental and proliferative defects in response to BCR stimulation in class IA PI3K-deficient B cells. These results show that the PI3K-mediated control of c-Rel expression is essential for B-cell functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18927440     DOI: 10.1182/blood-2008-06-163725

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Locus category based analysis of a large genome-wide association study of rheumatoid arthritis.

Authors:  Jan Freudenberg; Annette T Lee; Katherine A Siminovitch; Christopher I Amos; David Ballard; Wentian Li; Peter K Gregersen
Journal:  Hum Mol Genet       Date:  2010-07-16       Impact factor: 6.150

Review 2.  Metabolic Regulation of the Immune Humoral Response.

Authors:  Mark Boothby; Robert C Rickert
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

3.  Role of Bruton's tyrosine kinase inhibitors in HIV-1-infected cells.

Authors:  Irene Guendel; Sergey Iordanskiy; Gavin C Sampey; Rachel Van Duyne; Valerie Calvert; Emanuel Petricoin; Mohammed Saifuddin; Kylene Kehn-Hall; Fatah Kashanchi
Journal:  J Neurovirol       Date:  2015-02-12       Impact factor: 2.643

4.  PI3 kinase signals BCR-dependent mature B cell survival.

Authors:  Lakshmi Srinivasan; Yoshiteru Sasaki; Dinis Pedro Calado; Baochun Zhang; Ji Hye Paik; Ronald A DePinho; Jeffrey L Kutok; John F Kearney; Kevin L Otipoby; Klaus Rajewsky
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

Review 5.  PI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL).

Authors:  Klaus Okkenhaug; Jan A Burger
Journal:  Curr Top Microbiol Immunol       Date:  2016       Impact factor: 4.291

6.  [Expression and prognostic value of AKT2 in non-small cell lung cancer].

Authors:  Xiaohui Miao; Yong Song; Tangfeng Lv; Ping Zhan; Yanling Lv; Dongmei Yuan
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-05

Review 7.  Signaling by the phosphoinositide 3-kinase family in immune cells.

Authors:  Klaus Okkenhaug
Journal:  Annu Rev Immunol       Date:  2013-01-16       Impact factor: 28.527

8.  Knockdown of HSDL2 inhibits lung adenocarcinoma progression via down-regulating AKT2 expression.

Authors:  Yujia Shi; Zhengdao Mao; Yanhua Huang; Yun Sun; Qi Cao; Xiaowei Yin; Jianan Huang; Qian Zhang
Journal:  Biosci Rep       Date:  2020-04-30       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.